“One of the biggest obstacles that modern day society faces is the overwhelming cost of healthcare. Increasing changes are continuously being introduced, while simultaneously, resources are being diminished. The concepts of Regenerative Medicine offer cost-effective solutions. Besides the dwindling resources and socio-economic changes introduced by an ageing population, one of the major challenges in today’s industrialised world is the overburdening cost of healthcare (1). Regenerative Medicine (RegenMed) offers a solution to address this challenge. However, it can be a highly complex approach to treating patients because it potentially requires the integration of numerous scientific and clinical disciplines, as well as appropriate infrastructures (2,3). To bring new RegenMed technologies to patients effectively, and to further accelerate the developmental pace for RegenMed therapies, strong and open collaborative efforts are needed.”
This article published in the January 2013 issue of European Biopharmaceutical Review , Samedan Ltd, details how effective technology can help prevent the development of new cell lines being inhibited by data management systems. Power to the Database!
For more updates on pharma, biotech and R&D, follow us on Twitter: @totalbiopharma or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D